RT Journal Article
SR Electronic
T1 Analysis of the Interventions Adopted Due to the COVID-19 on Ari Morbility for Colombia
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.12.20193334
DO 10.1101/2020.09.12.20193334
A1 Quijano-Angarita, Á.
A1 Espinosa, O.
A1 Mercado, M.
A1 Walteros, D.
A1 Malo, D.
YR 2020
UL http://medrxiv.org/content/early/2020/09/14/2020.09.12.20193334.abstract
AB Acute Respiratory Infections are among the leading causes of death globally, particularly in developing countries, and are highly correlated with the quality of health and surveillance systems and effective early interventions in high-risk age groups. According to the World Health Organization, about four million people die each year from mostly preventable respiratory tract infections, making it a public health concern. The official declaration of a pandemic in March 2020 due to the Sars-CoV-2 virus coincided with the influenza season in Colombia and with environmental alerts about low air quality that increase its incidence. The objective of this document is the application of a flexible model for the identification of the pattern and monitoring of ARI morbility for Colombia by age group that shows atypical patterns in the reported series for 5 departments and that coincide with the decisions implemented to contain the COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by Instituto de Evaluacion Tecnologica en Salud and Instituto Nacional de Salud from Colombia. The institutions did not receive any third-party funds.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This is a statistical modelling study, which does not require registrationAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are not available because they are sensitive health data, and are protected by Colombia's habeas data law (Ley 1581 de 2012).